股本结构
单位：万股
| 公告日期 | 2024-04-15 | 2024-04-15 | 2024-02-28 | 2024-02-28 | 2023-11-08 | 2023-11-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 23177.15 | 23176.98 | 22822.02 | 22606.30 | 22596.77 | 22595.81 |
| 普通股本 | 23177.15 | 23176.98 | 22822.02 | 22606.30 | 22596.77 | 22595.81 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-08 | 2024-04-01 | 2024-02-23 | 2023-12-31 | 2023-11-03 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-15 | 23177.15 | 未披露 | 定期报告 | 2024-04-08 |
| 2024-04-15 | 23176.98 | 未披露 | 定期报告 | 2024-04-01 |
| 2024-02-28 | 22822.02 | 未披露 | 定期报告 | 2024-02-23 |
| 2024-02-28 | 22606.30 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Vesting of Restricted Stock Units, net of shares withheld for taxes
Exercise of stock options
Cashless exercise of warrants
|
2023-12-31 |
| 2023-11-08 | 22596.77 | 未披露 | 定期报告 | 2023-11-03 |
| 2023-11-08 | 22595.81 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of Restricted Stock Units, net of shares withheld for taxes
|
2023-09-30 |
| 2023-08-09 | 22490.64 | 未披露 | 定期报告 | 2023-08-04 |
| 2023-08-09 | 22452.67 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Cashless exercise of warrants
Exercise of stock options
Vesting of Restricted Stock Units, net of shares withheld for taxes
|
2023-06-30 |
| 2023-05-10 | 22227.30 | 未披露 | 定期报告 | 2023-05-05 |
| 2023-04-13 | 22224.93 | 未披露 | 定期报告 | 2023-04-10 |
| 2023-05-10 | 22226.26 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Exercise of stock options
Vesting of Restricted Stock Units, net of shares withheld for taxes
|
2023-03-31 |
| 2023-03-23 | 22215.56 | 未披露 | 定期报告 | 2023-03-17 |
| 2023-03-23 | 22181.69 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock, net of offering expenses
Vesting of Restricted Stock Units, net of shares withheld for taxes
Stock options exercised
|
2022-12-31 |
| 2022-12-07 | 21775.63 | 未披露 |
更多>>
Common stock offered 20,979,020 shares by the company
|
2022-12-09 |
| 2022-11-09 | 19677.73 | 未披露 | 定期报告 | 2022-11-04 |
| 2022-11-09 | 19677.69 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of Restricted Stock Units, net of shares withheld for taxes
|
2022-09-30 |
| 2022-08-10 | 19635.71 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-10 | 19635.62 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
|
2022-06-30 |
| 2022-05-11 | 19635.19 | 未披露 | 定期报告 | 2022-05-06 |
| 2022-04-28 | 19609.18 | 未披露 | 定期报告 | 2022-04-25 |
| 2022-04-28 | 19608.74 | 未披露 | 定期报告 | 2022-04-15 |
| 2022-05-11 | 19634.75 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
|
2022-03-31 |
| 2022-03-24 | 19592.04 | 未披露 | 定期报告 | 2022-03-18 |
| 2022-03-24 | 19581.38 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock, net of offering expenses
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
|
2021-12-31 |
| 2021-10-25 | 18187.20 | 未披露 |
更多>>
1.Common stock offered by company 50,000,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 131,872,026 shares of common stock outstanding as of June 30, 2021.
|
2021-10-25 |
| 2021-11-10 | 13831.38 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock, net of offering expenses
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
|
2021-09-30 |
| 2021-08-11 | 13276.95 | 未披露 | 定期报告 | 2021-08-06 |
| 2021-08-11 | 13187.20 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock, net of offering expenses
|
2021-06-30 |
| 2021-05-12 | 12818.96 | 未披露 | 定期报告 | 2021-05-07 |
| 2021-05-12 | 12304.50 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
Issuance of common stock, net of offering expenses
|
2021-03-31 |
| 2021-03-25 | 12127.54 | 未披露 | 定期报告 | 2021-03-16 |
| 2021-03-25 | 10490.29 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Vesting of Restricted Stock Units
Issuance of common stock, net of offering expenses
Stock options exercised
|
2020-12-31 |
| 2020-11-05 | 9454.81 | 未披露 | 定期报告 | 2020-11-05 |
| 2020-11-05 | 8961.62 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Vesting of restricted stock units
Issuance of common stock, net of offering expenses
|
2020-09-30 |
| 2020-08-05 | 8635.00 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of stock options
|
2020-06-30 |
| 2020-05-06 | 8634.53 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock, net of offering expenses
Exercise of stock options
|
2020-03-31 |
| 2020-03-13 | 8634.53 | 未披露 | 定期报告 | 2020-03-10 |
| 2020-02-11 | 8281.84 | 未披露 |
更多>>
On February 11, 2020, ADMA Biologics, Inc., a Delaware corporation (the “Company”), announced that it has completed its previously announced sale of an aggregate of 23,500,000 shares of common stock, $0.0001 par value per share (the “Common Stock”), pursuant to the Company’s existing shelf registration statement on Form S-3 (File No. 333-234107) (the “Offering”).
|
2020-02-11 |
| 2019-11-06 | 5931.84 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Exercise of stock options
|
2019-09-30 |
| 2019-08-08 | 5931.78 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Exercise of stock options
Issuance of common stock, net of offering expenses
|
2019-06-30 |
| 2019-07-16 | 5931.78 | 未披露 | 定期报告 | 2019-06-26 |
| 2019-05-21 | 5929.06 | 未披露 | 定期报告 | 2019-05-21 |
| 2019-05-08 | 4638.03 | 未披露 | 定期报告 | 2019-05-07 |
| 2019-03-13 | 4635.31 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Issuance of common stock, net of offering expenses
Stock options exercised
Retirement of non-voting common stock
|
2018-12-31 |
| 2018-11-09 | 4635.12 | 未披露 |
更多>>
From January 1, 2018 to September 30, 2018
Issuance of common stock, net of offering expenses
Stock options exercised
Retirement of non-voting common stock
|
2018-09-30 |
| 2018-08-10 | 4634.95 | 未披露 |
更多>>
From January 1, 2018 to June 30, 2018
Stock options exercised
Issuance of common stock, net of offering expenses
Retirement of Non-voting common stock
|
2018-06-30 |
| 2018-05-14 | 4531.72 | 未披露 |
更多>>
From January 1, 2018 to March 31, 2018
Stock options exercised
|
2018-03-31 |
| 2018-03-29 | 4531.72 | 未披露 | 定期报告 | 2018-03-09 |
| 2018-03-29 | 4531.67 | 未披露 |
更多>>
From December 31, 2016 To December 31, 2017
Shares issued in connection with acquisition
Issuance of common stock, net of offering expenses
Stock options exercised
|
2017-12-31 |
| 2017-11-03 | 2579.34 | 未披露 |
更多>>
From January 1, 2017 To September 30, 2017
Shares issued in connection with acquisition
Stock options exercised
|
2017-09-30 |
| 2017-08-11 | 2579.34 | 未披露 | 定期报告 | 2017-08-11 |
| 2017-08-11 | 2577.35 | 未披露 |
更多>>
from January 1, 2017 to June 30, 2017
Shares issued in connection with acquisition
|
2017-06-30 |
| 2017-05-12 | 1288.67 | 未披露 | 定期报告 | 2017-03-31 |
| 2016-08-12 | 1288.67 | 未披露 |
更多>>
From January 1, 2016 to May 13, 2016
Restricted shares
Issuance of common stock, net
|
2016-05-13 |
| 2016-04-29 | 1071.06 | 未披露 | 定期报告 | 2016-04-25 |
| 2015-11-10 | 1071.31 | 未披露 |
更多>>
from January 1, 2015 to September 30, 2015
Issuance of common stock, net
Stock issued in connection with stock options exercised
Restricted stock
|
2015-09-30 |
| 2015-05-12 | 1070.56 | 未披露 |
更多>>
from January 1, 2015 to March 31, 2015
Issuance of common stock, net
Issuance of restricted stock
|
2015-03-31 |
| 2014-11-10 | 929.18 | 未披露 | 定期报告 | 2014-09-30 |
From December 31, 2022 to December 31, 2023
Vesting of Restricted Stock Units, net of shares withheld for taxes
Exercise of stock options
Cashless exercise of warrants
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of Restricted Stock Units, net of shares withheld for taxes
From March 31, 2023 to June 30, 2023
Cashless exercise of warrants
Exercise of stock options
Vesting of Restricted Stock Units, net of shares withheld for taxes
From December 31, 2022 to March 31, 2023
Exercise of stock options
Vesting of Restricted Stock Units, net of shares withheld for taxes
From December 31, 2021 to December 31, 2022
Issuance of common stock, net of offering expenses
Vesting of Restricted Stock Units, net of shares withheld for taxes
Stock options exercised
Common stock offered 20,979,020 shares by the company
From June 30, 2022 to September 30, 2022
Vesting of Restricted Stock Units, net of shares withheld for taxes
From March 31, 2022 to June 30, 2022
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
From December 31, 2021 to March 31, 2022
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
From December 31, 2020 to December 31, 2021
Issuance of common stock, net of offering expenses
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
1.Common stock offered by company 50,000,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 131,872,026 shares of common stock outstanding as of June 30, 2021.
From June 30, 2021 to September 30, 2021
Issuance of common stock, net of offering expenses
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
From March 31, 2021 to June 30, 2021
Issuance of common stock, net of offering expenses
From December 31, 2020 to March 31, 2021
Vesting of Restricted Stock Units, net of shares withheld for taxes and retired
Issuance of common stock, net of offering expenses
From December 31, 2019 to December 31, 2020
Vesting of Restricted Stock Units
Issuance of common stock, net of offering expenses
Stock options exercised
From June 30, 2020 to September 30, 2020
Vesting of restricted stock units
Issuance of common stock, net of offering expenses
From March 31, 2020 to June 30, 2020
Exercise of stock options
From December 31, 2019 to March 31, 2020
Issuance of common stock, net of offering expenses
Exercise of stock options
On February 11, 2020, ADMA Biologics, Inc., a Delaware corporation (the “Company”), announced that it has completed its previously announced sale of an aggregate of 23,500,000 shares of common stock, $0.0001 par value per share (the “Common Stock”), pursuant to the Company’s existing shelf registration statement on Form S-3 (File No. 333-234107) (the “Offering”).
From June 30, 2019 to September 30, 2019
Exercise of stock options
from March 31, 2019 to June 30,2019
Exercise of stock options
Issuance of common stock, net of offering expenses
From December 31, 2017 to December 31, 2018
Issuance of common stock, net of offering expenses
Stock options exercised
Retirement of non-voting common stock
From January 1, 2018 to September 30, 2018
Issuance of common stock, net of offering expenses
Stock options exercised
Retirement of non-voting common stock
From January 1, 2018 to June 30, 2018
Stock options exercised
Issuance of common stock, net of offering expenses
Retirement of Non-voting common stock
From January 1, 2018 to March 31, 2018
Stock options exercised
From December 31, 2016 To December 31, 2017
Shares issued in connection with acquisition
Issuance of common stock, net of offering expenses
Stock options exercised
From January 1, 2017 To September 30, 2017
Shares issued in connection with acquisition
Stock options exercised
from January 1, 2017 to June 30, 2017
Shares issued in connection with acquisition
From January 1, 2016 to May 13, 2016
Restricted shares
Issuance of common stock, net
from January 1, 2015 to September 30, 2015
Issuance of common stock, net
Stock issued in connection with stock options exercised
Restricted stock
from January 1, 2015 to March 31, 2015
Issuance of common stock, net
Issuance of restricted stock